isoxazoles has been researched along with Gynecomastia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boot, AM; Buitelaar, JK; Roke, Y; Tenback, D; van Harten, PN | 1 |
| Hattori, H; Ikeda, A; Kimura, J; Odani, A; Shibasaki, H | 1 |
2 other study(ies) available for isoxazoles and Gynecomastia
| Article | Year |
|---|---|
Risk of hyperprolactinemia and sexual side effects in males 10-20 years old diagnosed with autism spectrum disorders or disruptive behavior disorder and treated with risperidone.
Topics: Adolescent; Adult; Antipsychotic Agents; Attention Deficit and Disruptive Behavior Disorders; Child; Child Development Disorders, Pervasive; Cross-Sectional Studies; Dose-Response Relationship, Drug; Gynecomastia; Humans; Hyperprolactinemia; Isoxazoles; Logistic Models; Male; Paliperidone Palmitate; Prolactin; Pyrimidines; Risperidone; Sexual Dysfunction, Physiological; Statistics, Nonparametric; Surveys and Questionnaires; Time Factors; Young Adult | 2012 |
Gynaecomastia in association with phenytoin and zonisamide in a patient having a CYP2C subfamily mutation.
Topics: Adult; Anticonvulsants; Epilepsies, Partial; Gynecomastia; Humans; Isoxazoles; Male; Metabolism, Inborn Errors; Phenytoin; Point Mutation; Zonisamide | 1998 |